Kwality Pharmaceuticals Ltd. (KPL): Kwality Pharmaceuticals Share Price Hits Fresh 52-Week High at Rs 3,725.45

Kwality Pharmaceuticals Share Price rose to Rs 3,725.45, up 8.15% today, marking a fresh 52-week high. The company’s market capitalisation stood at Rs 3,574.34 crore.

Kwality Pharmaceuticals Share Price climbed to Rs 3,725.45 on 17 August 2026, up Rs 280.70 or 8.15% from the previous close of Rs 3,444.75, and in the process touched a fresh 52-week high. With the move, the company’s market capitalisation stood at Rs 3,574.34 crore. For traders scanning 52 Week High Stocks and Stocks in News, this places Kwality Pharmaceuticals Ltd. firmly on the early market radar.

Today’s price action is notable because the stock’s day high and its fresh one-year high were the same at Rs 3,725.45, showing that the strongest traded level of the session also marked the yearly high. The supplied data confirms the price event, the size of the move and the turnover, but it does not establish a company-specific catalyst behind the rise.

For investors following Kwality Pharmaceuticals Share Price Today and broader Share Market Today trends, the immediate focus is on three verified areas: the sharp move from the previous close, the stock’s valuation against the Healthcare sector benchmark, and how its profitability ratios compare with peers. Univest analysis also suggests that the stock is drawing attention because the market-cap profile is now larger than the same-sector median and average figures supplied in the benchmark snapshot.

Kwality Pharmaceuticals Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 3,725.45
Previous Close	Rs 3,444.75
Today's Change	+Rs 280.7 (+8.15%)
Day Open	Rs 3,502
Fresh 52-Week High	Rs 3,725.45
Day Low	Rs 3,501.95
Current Volume	1,597
Turnover	Rs 0.59 crore
Market Capitalisation	Rs 3,574.34 crore

Kwality Pharmaceuticals Ltd. (KPL) traded at Rs 3,725.45. versus the previous close of Rs 3,444.75, a rise of 8.15%. The stock opened at Rs 3,502, reached Rs 3,725.45, touched Rs 3,501.95. Reported volume was 1,597.

Kwality Pharmaceuticals Share Price Today opened at Rs 3,502.00 and moved in a tight but upward intraday band before hitting a fresh 52-week high of Rs 3,725.45. Against the previous close of Rs 3,444.75, the stock gained Rs 280.70, while turnover stood at Rs 0.59 crore and current volume was 1,597 shares.

The day’s trading setup shows that the stock opened above the previous close and maintained strength through the session range. The day low was Rs 3,501.95, almost identical to the opening level of Rs 3,502.00, which indicates that the stock did not meaningfully slip below its initial traded zone before extending higher. The day high of Rs 3,725.45 was also the 52-week peak, confirming that the stock set a new yearly high during live trading.

In percentage terms, the jump of 8.15% is substantial for a single session move. For market participants tracking Kwality Pharmaceuticals Share Price Live, the data points to strong early price expansion rather than a marginal new high. Turnover of Rs 0.59 crore and volume of 1,597 shares show that the breakout to the one-year high came on measurable activity, even though the supplied dataset does not provide a longer average-volume comparison.

As Univest tracks this Kwality Pharmaceuticals Share Price Update, the key takeaway from price action alone is straightforward: the stock moved higher from open, stayed above the prior close, and printed a fresh 52-week peak. That naturally shifts attention from pure price action to whether the underlying valuation and profitability metrics support continued investor attention.

Kwality Pharmaceuticals Ltd. (KPL) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 3,574.34 crore
P/E Ratio	184.72x
P/B Ratio	0.45x
ROE	-2.89%
ROCE	-0.26%

Kwality Pharmaceuticals Ltd. was valued at a P/E ratio of 184.72x, a P/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	184.72x
Benchmark Median P/E	21.1x
Benchmark Average P/E	49.38x
Benchmark P/E Range	0x to 1,603.4x
Company P/B Ratio	0.45x
Benchmark Median P/B	1.9x
Company ROE	-2.89%
Benchmark Median ROE	10.71%
Company ROCE	-0.26%
Benchmark Median ROCE	13.15%
Company Market Capitalisation	Rs 3,574.34 crore
Benchmark Median Market Cap	Rs 135.27 crore

Kwality Pharmaceuticals Ltd. (KPL) is classified under sector: Healthcare.

Kwality Pharmaceuticals Ltd. (KPL) has a P/E ratio of 184.72x, which is above the benchmark median of 21.1x, a difference of +775.45%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Kwality Pharmaceuticals Ltd. (KPL) has a ROE of -2.89%, which is below the benchmark median of 10.71%, a difference of -126.98%. Kwality Pharmaceuticals Ltd. (KPL) has a ROCE of -0.26%, which is below the benchmark median of 13.15%, a difference of -101.98%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,985.15	184.72	0.45	-2.89	-0.26
Beta Drugs Ltd.	BETA	2,827.67	68.16	6.74	18.65	22.17
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,645.37	46.15	1.77	-0.78	8.31
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,612.26	34.27	7.07	-2.6	16.92
Fredun Pharmaceuticals Ltd.	FREDUN	2,559.68	58.41	8.73	11.42	13.15

Kwality Pharmaceuticals Ltd. (KPL) has a P/E ratio of 184.72x compared with the displayed peer median of 58.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. Kwality Pharmaceuticals Ltd. (KPL) has a market capitalisation of Rs 3,574.34 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Kwality Pharmaceuticals

Kwality Pharmaceuticals Share Price is attracting attention because the verified data combines a strong price event with unusual valuation and sector positioning. In the context of Stock Market Today and Top Gainers Today screens, these are the main points investors are watching.

• Fresh price milestone: the stock hit a new 52-week high of Rs 3,725.45 and closed the gap well above the previous close of Rs 3,444.75 during the session.
• Strong daily move: today’s gain was Rs 280.70, or 8.15%, which is meaningful for intraday Share Price News and Stock Updates tracking.
• Market-cap scale: market capitalisation at Rs 3,574.34 crore is above both the Healthcare benchmark median and average.
• Valuation divergence: P/E of 184.72 is above sector norms, while P/B of 0.45 is below them.
• Return ratios: ROE of -2.89 and ROCE of -0.26 remain below sector benchmark levels, keeping the financial picture mixed.
• Peer positioning: the stock is larger in market cap than the supplied peer basket, but profitability compares less favourably with several peers.

About Kwality Pharmaceuticals

Kwality Pharmaceuticals Ltd. (KPL) is a listed Indian company tracked on the exchanges under the symbol KPL. In the supplied dataset, the company is classified within the Healthcare sector, which provides the main basis for sector and peer comparison in this article.

From a market perspective, the company is currently being evaluated alongside other Healthcare names in a 201-company same-sector benchmark and against a smaller listed peer set that includes pharmaceutical and healthcare businesses. That context matters because current investor attention is being driven less by a broad company profile disclosure in the supplied data and more by measurable stock-market signals such as the fresh 52-week high, market capitalisation, valuation multiples and return ratios.

For readers tracking Kwality Pharmaceuticals Company News, Kwality Pharmaceuticals Latest News and Kwality Pharmaceuticals Share News, the most verified current context is that the company has entered the spotlight through a fresh yearly high within the Healthcare pack. Univest will typically view such moves through price action, valuation, sector placement and peer comparison rather than through unsupported assumptions.

Track Kwality Pharmaceuticals Share Price on Univest

Use Kwality Pharmaceuticals Ltd. (KPL) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors following Kwality Pharmaceuticals Share Price can track live share price moves, 52-week levels, market-cap changes, valuation ratios, peer positioning and broader market insights on Univest. The platform helps users monitor Kwality Pharmaceuticals Share Price Today alongside sector context, stock performance and verified data points that matter during event-led sessions.

For users researching Kwality Pharmaceuticals NSE and Kwality Pharmaceuticals BSE trends, Univest brings together Share Price Live tracking, fundamental ratios, sector comparisons and market updates in one place. That can help investors follow how a fresh 52 Week High develops over time without relying on speculation.

Frequently Asked Questions

What is the latest Kwality Pharmaceuticals Share Price Today?

Ans. Kwality Pharmaceuticals Share Price Today was Rs 3,725.45 in the supplied market snapshot. The stock was up Rs 280.70 or 8.15% from the previous close of Rs 3,444.75, making it one of the notable stocks in news.

Did Kwality Pharmaceuticals hit a fresh 52-week high today?

Ans. Yes, the stock touched a fresh 52-week high of Rs 3,725.45. That was also the day’s high, which means the strongest traded price of the session coincided exactly with the new one-year high level.

Why is Kwality Pharmaceuticals Share Price rising today?

Ans. The supplied data confirms that Kwality Pharmaceuticals Share Price rose 8.15% and hit a fresh 52-week high. It verifies the market move, turnover and valuation context, but it does not establish a company-specific catalyst behind today’s rise.

What were the opening, high and low levels for the stock?

Ans. The stock opened at Rs 3,502.00, touched a high of Rs 3,725.45 and recorded a low of Rs 3,501.95. This shows the session’s low stayed near the opening level before the price extended higher.

What is the market capitalisation of Kwality Pharmaceuticals Ltd.?

Ans. The company’s market capitalisation stood at Rs 3,574.34 crore in the supplied data. That figure is above the Healthcare sector benchmark median of Rs 135.27 crore and the benchmark average of Rs 456.49 crore.

How is Kwality Pharmaceuticals valued on P/E and P/B?

Ans. Kwality Pharmaceuticals was trading at a P/E ratio of 184.72 and a P/B ratio of 0.45. Its P/E is above the Healthcare sector median of 21.1, while its P/B is below the sector median of 1.9.

What do the ROE and ROCE figures show?

Ans. The supplied profitability snapshot shows ROE at -2.89 and ROCE at -0.26. Both figures are below the Healthcare benchmark medians of 10.71 for ROE and 13.15 for ROCE, indicating weaker return ratios versus the sector.

How does Kwality Pharmaceuticals compare with its supplied peers?

Ans. Kwality Pharmaceuticals has a market cap of Rs 3,574.34 crore, higher than the supplied peer set. However, its P/E of 184.72 is above most peers, while ROE and ROCE compare less favourably against several companies listed alongside it.

Which sector does Kwality Pharmaceuticals belong to?

Ans. Kwality Pharmaceuticals Ltd. is classified in the Healthcare sector in the supplied dataset. The sector benchmark used for comparison covers 201 companies, giving context to the stock’s current valuation, market capitalisation and return ratios.

What should investors monitor after this fresh 52-week high?

Ans. Investors can monitor whether Kwality Pharmaceuticals Share Price holds near the fresh 52-week peak, how valuation metrics compare with peers, and whether future financial performance improves from the current ROE of -2.89 and ROCE of -0.26.